Therapeutic efficacy of antimalarial drugs along the eastern Indo-Nepal border: A cross-border collaborative study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 99, Issue 6, 2005, Pages 423-429

  Wijeyaratne, Pandu M ^a,b   Chand, P B ^b   Valecha, N ^c   Shahi, B ^c   Adak, T ^c   Ansari, M A ^c   Jha, J ^d   Pandey, S ^e   Bannerjee, S ^f   Bista, M B ^g  

^a EHP/USAID   (Nepal)

^b Department of Health Services ^*  (Sri Lanka)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^d Child Health Division   (Nepal)

^e Environmental Health Project   (Nepal)

^f State Health Services   (India)

^g Minister for Health and Population Nepal   (Nepal)

Author keywords

Chloroquine; Drug resistance; Indo Nepal border; Malaria; Sulfadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; PARACETAMOL; PRIMAQUINE; QUININE SULFATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INDIA; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MIGRATION; NEPAL; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; SIDE EFFECT; TABLET; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INDIA; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NEPAL; PYRIMETHAMINE; SEX DISTRIBUTION; SULFADOXINE; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM;

EID: 20244367616     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2004.09.011     Document Type: Article

References (16)

1. Bloland, P.B., 2001. Drug resistance in malaria. World Health Organization, Geneva, WHO/CDS/CSR/DRS/2001.4.
2. S.K. Ghosh R.S. Yadav V.P. Sharma Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of district Sundargarh, Orissa Indian J. Malariol. 29 1992 211-218
3. Jung, 2001 R.K. Jung History of malaria and malaria control in Nepal 2001 Aravali Printers & Publisher P. Ltd New Delhi
4. Ministry of Health, Kathmandu, New ERA, ORC Macro, 2002. Nepal Demographic and Health Survey 2001. Family Health Division, Ministry of Health; New ERA; and ORC Macro, Calverton, MD.
5. Ministry of Health, Kathmandu, 2003. Annual Report of Malaria/Kala-azar and J.E. Control Programme in Jhapa District 2003. Department of Health Services, District Public Health Office, Jhapa.
6. Ministry of Health, Kathmandu, 2004a. Malaria and Kala-azar control activities 2002. Department of Health Services, Kathmandu.
7. Ministry of Health, Kathmandu, 2004b. Annual Report 2002/2003. Department of Health Services, Kathmandu.
8. B.N. Nagpal V.P. Sharma Indian Anopheles 1995 Oxford and IPH Publishing Company Pvt. Ltd New Delhi
9. P.N. Sehgal M.I.D. Sharma S. Gogal Resistance to chloroquine in falciparum malaria in Assam state India J. Commun. Dis. 5 1973 175-180
10. V.P. Sharma Status of drug resistance in malaria in India In: R.C. Mahajan (Eds.) Multi Drug Resistance in Emerging and Re-emerging Diseases 2000 INSA Narosa Publication New Delhi 191-203
11. N. Singh M.M. Shukla Response of Plasmodium falciparum to chloroquine in a tribal area of Madhya Pradesh Indian J. Malariol. 27 1990 183-186
12. WHO, 1973. Chemotherapy of Malaria and Resistance to Antimalarials. Report of a WHO Scientific Group. World Health Organization, Geneva, Technical Report Series, No. 529.
13. WHO, 2001a. The use of Antimalarial Drugs. World Health Organization, Geneva, WHO/CDS/RBM/2001.33.
14. WHO, 2001b. Antimalarial Drug Combination Therapy. World Health Organization, Geneva, WHO/CDS/RBM/2001.35.
15. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.50.
16. Wijeyaratne, P.M., Valeecha, N., Joshi, A.B., Singh, D., Pandey, S., 2004. An inventory of malaria drug resistance in Bangladesh, Bhutan, India and Nepal. HMG/MOH/USAID programme for the prevention and control of selected infectious diseases, In: Environmental Health Project Activity Report, No. 130, Available from World Wide Web: http://www.ehproject.org/Pubs/Activity_Reports.htm.